Green Thumb Industries Inc. (GTBIF)
(Delayed Data from OTC)
$10.29 USD
-0.05 (-0.48%)
Updated Sep 12, 2024 03:59 PM ET
3-Hold of 5 3
A Value B Growth F Momentum B VGM
Brokerage Reports
Green Thumb Industries Inc. [GTBIF]
Reports for Purchase
Showing records 81 - 100 ( 142 total )
Company: Green Thumb Industries Inc.
Industry: Medical - Products
Consumer- Weekly ReHash: Another Rough Quarter for Cannabis
Provider: Roth Capital Partners, Inc.
Analyst: FORTUNE S
Company: Green Thumb Industries Inc.
Industry: Medical - Products
Tightening Capital Markets Conditions Poses Both Risks and Opportunities for Cannabis Companies
Provider: Echelon Welath Partners
Analyst: SEMPLE A
Company: Green Thumb Industries Inc.
Industry: Medical - Products
Weekly ReHash: Cannabis Earnings Week 2: Week 1 Takeaways
Provider: Roth Capital Partners, Inc.
Analyst: FORTUNE S
Company: Green Thumb Industries Inc.
Industry: Medical - Products
Company: Green Thumb Industries Inc.
Industry: Medical - Products
Company: Green Thumb Industries Inc.
Industry: Medical - Products
Cannabis Industry: Monthly Performance and Valuations February ''23
Provider: Roth Capital Partners, Inc.
Analyst: FORTUNE S
Company: Green Thumb Industries Inc.
Industry: Medical - Products
Company: Green Thumb Industries Inc.
Industry: Medical - Products
Stability in the Face of Significant Pricing Pressure, Forward Commentary Points to Another Modest Year Ahead, PT to C$32/shr
Provider: Echelon Welath Partners
Analyst: SEMPLE A
Company: Green Thumb Industries Inc.
Industry: Medical - Products
4Q22 Margin Pressure on NT Pricing But Generating OCF, PT to $16
Provider: Roth Capital Partners, Inc.
Analyst: FORTUNE S
Company: Green Thumb Industries Inc.
Industry: Medical - Products
Company: Green Thumb Industries Inc.
Industry: Medical - Products
Weekly ReHash: Cannabis Week - Earnings Preview
Provider: Roth Capital Partners, Inc.
Analyst: Research Department
Company: Green Thumb Industries Inc.
Industry: Medical - Products
Cannabis State of the Union: A Year of Resiliency With Focus on 2024
Provider: Roth Capital Partners, Inc.
Analyst: FORTUNE S
Company: Green Thumb Industries Inc.
Industry: Medical - Products
Weekly ReHash: 280E Removal Would Bring More Than Just Financial Leverage
Provider: Roth Capital Partners, Inc.
Analyst: FORTUNE S
Company: Green Thumb Industries Inc.
Industry: Medical - Products
Weekly Rehash: U.S. Interstate Commerce the Long Game
Provider: Roth Capital Partners, Inc.
Analyst: FORTUNE S
Company: Green Thumb Industries Inc.
Industry: Medical - Products
Company: Green Thumb Industries Inc.
Industry: Medical - Products
Weekly ReHash: Industry Preserving Cash in Prep for a Nuclear Winter
Provider: Roth Capital Partners, Inc.
Analyst: FORTUNE S
Company: Green Thumb Industries Inc.
Industry: Medical - Products
Weekly ReHash: Scoring the MSOs with Cash Flow, Debt and Valuations
Provider: Roth Capital Partners, Inc.
Analyst: FORTUNE S
Company: Green Thumb Industries Inc.
Industry: Medical - Products
Weekly ReHash: Pricing is Key to Improving Industry Fundamentals
Provider: Roth Capital Partners, Inc.
Analyst: FORTUNE S
Company: Green Thumb Industries Inc.
Industry: Medical - Products
Weekly ReHash: Putting 2022 Performance & Valuations Behind Us
Provider: Roth Capital Partners, Inc.
Analyst: FORTUNE S